188 related articles for article (PubMed ID: 1997703)
1. Radical prostatectomy and adjuvant radioactive gold seed placement: results of treatment at 5 and 10 years for clinical stages A2, B1 and B2 cancer of the prostate.
Kwon ED; Loening SA; Hawtrey CE
J Urol; 1991 Mar; 145(3):524-31. PubMed ID: 1997703
[TBL] [Abstract][Full Text] [Related]
2. Survival of patients with localized prostate cancer treated with percutaneous transperineal placement of radioactive gold seeds: stages A2, B, and C.
Hochstetler JA; Kreder KJ; Brown CK; Loening SA
Prostate; 1995 Jun; 26(6):316-24. PubMed ID: 7784271
[TBL] [Abstract][Full Text] [Related]
3. Radical prostatectomy with adjuvant radioactive gold for prostatic cancer: a preliminary report.
Rosenberg SJ; Loening SA; Hawtrey CE; Narayana AS; Culp DA
J Urol; 1985 Feb; 133(2):225-7. PubMed ID: 3968737
[TBL] [Abstract][Full Text] [Related]
4. Morbidity and mortality of local failure after definitive therapy for prostate cancer.
Schellhammer PF; Whitmore RB; Kuban DA; el-Mahdi AM; Ladaga LA
J Urol; 1989 Mar; 141(3):567-71. PubMed ID: 2918594
[TBL] [Abstract][Full Text] [Related]
5. Radical retropubic prostatectomy and postoperative adjuvant radiation for pathological stage C (PcN0) prostate cancer from 1976 to 1989: intermediate findings.
Freeman JA; Lieskovsky G; Cook DW; Petrovich Z; Chen S; Groshen S; Skinner DG
J Urol; 1993 May; 149(5):1029-34. PubMed ID: 8483203
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant radiation, chemotherapy, and androgen deprivation therapy for pathologic stage D1 adenocarcinoma of the prostate.
Freeman JA; Lieskovsky G; Grossfeld G; Esrig D; Stein JP; Cook DW; Petrovich Z; Chen SC; Groshen S; Skinner DG
Urology; 1994 Nov; 44(5):719-25. PubMed ID: 7526528
[TBL] [Abstract][Full Text] [Related]
7. Gold seed implantation in prostate brachytherapy.
Loening SA
Semin Surg Oncol; 1997; 13(6):419-24. PubMed ID: 9358588
[TBL] [Abstract][Full Text] [Related]
8. Results of radical perineal prostatectomy with adjuvant brachytherapy.
Doornbos JF; Hussey DH; Robinson RA; Wen BC; Vigliotti AP
Radiology; 1992 Aug; 184(2):333-9. PubMed ID: 1620824
[TBL] [Abstract][Full Text] [Related]
9. Five-year biochemical recurrence-free and overall survival following high-dose-rate brachytherapy with additional external beam or radical prostatectomy in patients with clinically localized prostate cancer.
Boehm K; Schiffmann J; Tian Z; Lesmana H; Larcher A; Mandel P; Karakiewicz PI; Graefen M; Schwarz R; Krüll A; Tilki D
Urol Oncol; 2016 Mar; 34(3):119.e11-8. PubMed ID: 26602027
[TBL] [Abstract][Full Text] [Related]
10. Surgery with adjuvant irradiation in patients with pathologic stage C adenocarcinoma of the prostate.
Petrovich Z; Lieskovsky G; Freeman J; Luxton G; Groshen S; Formenti S; Baert L; Chen SC; Skinner DG
Cancer; 1995 Nov; 76(9):1621-8. PubMed ID: 8635067
[TBL] [Abstract][Full Text] [Related]
11. Comparison of outcomes of radical prostatectomy with and without adjuvant pelvic irradiation in patients with pathologic stage C (T3N0) adenocarcinoma of the prostate.
Petrovich Z; Lieskovsky G; Langholz B; Bochner B; Formenti S; Streeter O; Skinner DG
Am J Clin Oncol; 1999 Aug; 22(4):323-31. PubMed ID: 10440184
[TBL] [Abstract][Full Text] [Related]
12. Cancer control following anatomical radical prostatectomy: an interim report.
Morton RA; Steiner MS; Walsh PC
J Urol; 1991 Jun; 145(6):1197-200. PubMed ID: 1709704
[TBL] [Abstract][Full Text] [Related]
13. Adenocarcinoma of the prostate: radioactive gold seed implant plus external irradiation.
Gutierrez AE; Merino OR
Int J Radiat Oncol Biol Phys; 1988 Dec; 15(6):1317-22. PubMed ID: 3143692
[TBL] [Abstract][Full Text] [Related]
14. Long-term results of combined interstitial gold seed implantation plus external beam irradiation in localised carcinoma of the prostate.
Lannon SG; el-Araby AA; Joseph PK; Eastwood BJ; Awad SA
Br J Urol; 1993 Nov; 72(5 Pt 2):782-91. PubMed ID: 8281413
[TBL] [Abstract][Full Text] [Related]
15. Use of percutaneous transperineal 198Au seeds to treat recurrent prostate adenocarcinoma after failure of definitive radiotherapy.
Loening SA; Turner JW
Prostate; 1993; 23(4):283-90. PubMed ID: 8259342
[TBL] [Abstract][Full Text] [Related]
16. Results of local and/or systemic adjuvant therapy in the management of pathological stage C or D1 prostate cancer following radical prostatectomy.
Carter GE; Lieskovsky G; Skinner DG; Petrovich Z
J Urol; 1989 Nov; 142(5):1266-70; discussion 1270-1. PubMed ID: 2810504
[TBL] [Abstract][Full Text] [Related]
17. Bilateral pelvic lymphadenectomy and radical prostatectomy for clinical stage C prostatic cancer: role of adjuvant treatment for residual cancer and in disease progression.
Zincke H; Utz DC; Taylor WF
J Urol; 1986 Jun; 135(6):1199-205. PubMed ID: 3086572
[TBL] [Abstract][Full Text] [Related]
18. Hormonal treatment at time of radical retropubic prostatectomy for stage D1 prostate cancer: results of long-term followup.
Myers RP; Larson-Keller JJ; Bergstralh EJ; Zincke H; Oesterling JE; Lieber MM
J Urol; 1992 Mar; 147(3 Pt 2):910-5. PubMed ID: 1538495
[TBL] [Abstract][Full Text] [Related]
19. International Multicenter Validation of an Intermediate Risk Subclassification of Prostate Cancer Managed with Radical Treatment without Hormone Therapy.
Berlin A; Moraes FY; Sanmamed N; Glicksman R; Koven A; Espin-Garcia O; Leite ETT; Silva JLF; Gadia R; Nesbitt M; Catton CN; Kaffenberger S; Salami SS; Morgan TM; Hearn JWD; Jackson WC; Mehra R; Chung P; Fleshner NE; Zumsteg ZS; Dess RT; Feng FY; Finelli A; Spratt DE
J Urol; 2019 Feb; 201(2):284-291. PubMed ID: 30153435
[TBL] [Abstract][Full Text] [Related]
20. Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer.
Zincke H; Oesterling JE; Blute ML; Bergstralh EJ; Myers RP; Barrett DM
J Urol; 1994 Nov; 152(5 Pt 2):1850-7. PubMed ID: 7523733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
